Role of RNA structural plasticity in modulating HIV-1 genome packaging and translation.
HIV-1
dimerization
packaging
polyA
translation
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
13 Aug 2024
13 Aug 2024
Historique:
medline:
8
8
2024
pubmed:
7
8
2024
entrez:
7
8
2024
Statut:
ppublish
Résumé
HIV-1 transcript function is controlled in part by twinned transcriptional start site usage, where 5' capped RNAs beginning with a single guanosine (1G) are preferentially packaged into progeny virions as genomic RNA (gRNA) whereas those beginning with three sequential guanosines (3G) are retained in cells as mRNAs. In 3G transcripts, one of the additional guanosines base pairs with a cytosine located within a conserved 5' polyA element, resulting in formation of an extended 5' polyA structure as opposed to the hairpin structure formed in 1G RNAs. To understand how this remodeling influences overall transcript function, we applied in vitro biophysical studies with in-cell genome packaging and competitive translation assays to native and 5' polyA mutant transcripts generated with promoters that differentially produce 1G or 3G RNAs. We identified mutations that stabilize the 5' polyA hairpin structure in 3G RNAs, which promote RNA dimerization and Gag binding without sequestering the 5' cap. None of these 3G transcripts were competitively packaged, confirming that cap exposure is a dominant negative determinant of viral genome packaging. For all RNAs examined, conformations that favored 5' cap exposure were both poorly packaged and more efficiently translated than those that favored 5' cap sequestration. We propose that structural plasticity of 5' polyA and other conserved RNA elements place the 5' leader on a thermodynamic tipping point for low-energetic (~3 kcal/mol) control of global transcript structure and function.
Identifiants
pubmed: 39110735
doi: 10.1073/pnas.2407400121
doi:
Substances chimiques
RNA, Viral
0
RNA Caps
0
RNA, Messenger
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2407400121Subventions
Organisme : NIAID NIH HHS
ID : R01 AI150498
Pays : United States
Organisme : HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
ID : U54 AI70660
Organisme : NIAID NIH HHS
ID : R01 AI110221
Pays : United States
Organisme : NIAID NIH HHS
ID : F30 AI174890
Pays : United States
Organisme : HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
ID : 5T32 HL007698-26
Déclaration de conflit d'intérêts
Competing interests statement:The authors declare no competing interest.